Wampole B-50 Complex
Natural health product licensed in Canada
- Licence holder
- Wampole Group L.P.
- NPN or DIN-HM
- 80008064
- Status
- Active licence
- Licence date
- 15 October 2008
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine Source : Niacinamide | 50 mg | Not calculated |
| 1,2,3,5/4,6- hexahydroxycyclohexane Source : Zea mays | 50 mg | Not calculated |
| 1,2,3,5/4,6- hexahydroxycyclohexane Source : Maïs | 50 mg | Not calculated |
| Biotine Source : d-biotin | 50 mcg | Not calculated |
| 2-(hydroxyethyl)trimethylammonium Source : Bitartrate de choline | 150 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxal | 50 mg | Not calculated |
| Folate Source : Acide folique | 1 mg | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 50 mg | Not calculated |
Non-medicinal ingredients
Phosphate de dicalcium dihydrate, Ethylcellulose, Dioxyde de silicium, Stéarate de magnésium végétal, Huile végétale, cellulose, Dicalcium Phosphate Anhydrous, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | Not specified |
Uses authorised in Canada
B-complex vitamin for the maintenance of good health. Helps promote growth and development.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a physician prior to use if you are taking levodopa, or have impaired liver function.
- Effets indésirables connus
Discontinue use if you experience prolonged flushing, burning, tingling or itching sensation on the face, arms or chest.
Source
Official Health Canada record, licence 80008064
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.